Study of immune cells involved in the antitumor effect of kefir in a murine breast cancer model

Journal of Dairy Science

Volumn 90, Issue 4, 2007, Pages 1920-1928

  De Moreno De LeBlanc, A ^a,b,c   Matar, C ^a   Farnworth, E ^d   Perdigon G ^b,c  

^a UNIVERSITÉ DE MONCTON   (Canada)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^d FOOD RESEARCH AND DEVELOPMENT CENTRE   (Canada)

Author keywords

Breast cancer; Immune response; Kefir

Indexed keywords

MURINAE; MUS;

EID: 35949004479     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2006-079     Document Type: Article

References (28)

1. Belardelli, F., and M. Ferrantini. 2002. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol. 23:201-208.
2. Brandtzaeg, P., and R. Pabst. 2004. Let's go mucosal: Communication on slippery ground. Trends Immunol. 25:570-577.
3. Butler, L. M., P. J. Hewett, R. A. Fitridge, and P. A. Cowled. 1999. Deregulation of apoptosis in colorectal carcinoma: Theoretical and therapeutic implications. Aust. N. Z. J. Surg. 69:88-94.
4. Curotto de Lafaille, M. A., and J. J. Lafaille. 2002. CD4+ regulatory T cells in autoimmunity and allergy. Curr. Opin. Immunol. 14:771-778.
5. de Moreno de LeBlanc, A., C. Maldonado Galdeano, S. Chaves, and G. Perdigón. 2005. Oral administration of L. casei CRL 431 increases immunity in bronchus and mammary glands. Eur. J. Inflamm. 3:25-30.
6. de Moreno de LeBlanc, A., C. Matar, E. Farnworth, and G. Perdigon. 2006. Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine 34:1-8.
7. de Moreno de LeBlanc, A., C. Matar, N. LeBlanc, and G. Perdigon. 2005a. Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res. 7:477-486.
8. de Moreno de LeBlanc, A., C. Matar, C. Thériault, and G. Perdigon. 2005b. Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology 210:349-358.
9. de Moreno de LeBlanc. A., and G. Perdigón. 2005. Antitumor activity of yoghurt. Pages 115-140 in Focus on Colorectal Cancer Research. J. D. Martinez, ed. Nova Science Publishers, Hauppauge, NY.
10. de Moreno de LeBlanc, A., and G. Perdigón. 2004. Yoghurt feeding inhibits promotion and progression of experimental colorectal cancer. Med. Sci. Monit. 10:96-104.
11. de Moreno de LeBlanc, A., J. Valdéz, and G. Perdigón. 2004. Regulatory effect of yoghurt on intestinal inflammatory immune response. Eur. J. Inflamm. 2:21-61.
12. Drouault, S., and G. Corthier. 2001. Health effects of lactic acid bacteria ingested in fermented milk. Vet. Res. 32:101-117.
13. Farnworth, E. R., and I. Mainville. 2003. Kefir: A fermented milk product. Pages 77-111 in Handbook of Fermented Functional Foods. E. R. Farnworth, ed. CRC Press, Boca Raton, FL.
14. Furukawa, N., A. Matsuoka, T. Takahashi, and Y. Yamanaka. 1991. Effects of fermented milk on the delayed-type hypersensitivity response and survival in mice bearing Meth-A. Anim. Sci. Technol. 62:579-585.
15. Furukawa, N., A. Matsuoka, T. Takahashi, and Y. Yamanaka. 1990. Effects of orally administered yogurt and kefir on tumor growth in mice. J. Jpn. Soc. Nutr. Food Sci. 43:450-453.
16. Gavrieli, Y., Y. Sherman, and S. A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
17. Hao, X., M. Du, A. Bishop, and I. Talbot. 1998. Imbalance between proliferation and apoptosis in the development of colorectal carcinoma. Virchows Arch. 433:523-527.
18. LeBlanc, J. G., C. Matar, J. C. Valdez, J. LeBlanc, and G. Perdigón. 2002. Immunomodulatory effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J. Dairy Sci. 85:2733-2742.
19. Mainville, I., N. Robert, B. Lee, and E. R. Farnworth. 2006. Polyphasic characterization of the lactic acid bacteria in kefir. Syst. Appl. Microbiol. 29:59-68.
20. Osada, K., K. Nagira, K. Teruya, H. Tachibana, S. Shirahata, and H. Murakami. 1994. Enhancement of interferon-β production with sphingomyelin from fermented milk. Biotherapy 7:115-123.
21. Perdigón, G., A. de Moreno de LeBlanc, J. Valdez, and M. Rachid. 2002. Role of yoghurt in the prevention of colon cancer. Eur. J. Clin. Nutr. 56:S65-S68.
22. Perdigón, G., R. Fuller, and R. Raya. 2001. Lactic acid bacteria and their effect on the immune system. Curr. Issues Intest. Microbiol. 2:27-42.
23. Perdigón, G., E. Vintini, S. Alvarez, M. Medina, and M. Medici. 1999. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J. Dairy Sci. 82:1108-1114.
24. Read, S., and F. Powrie. 2001. CD4(+) regulatory T cells. Curr. Opin. Immunol. 13:644-649.
25. Sellers, W. R., and D. E. Fisher. 1999. Apoptosis and cancer drug targeting. J. Clin. Invest. 104:1655-1661.
26. Valdéz, J. C., M. Rachid, E. Bru, and G. Perdigón. 1997. The effect of yoghurt on the cytotoxic and phagocytic activity of macrophages in tumor-bearing mice. Food Agric. Immunol. 9:299-308.
27. Vinderola, C. G., J. Duarte, D. Thangavel, G. Perdigón, E. Farnworth, and C. Matar. 2005. Immunomodulating capacity of kefir. J. Dairy Res. 72:195-202.
28. Vinderola, C. G., G. Perdigón, J. Duarte, E. Farnworth, and C. Matar. 2006. Effects of the oral administration of the products derived from milk fermentation by kefir microflora on immune stimulation. J. Dairy Res. 73:472-479.